• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT TRIMA ACCEL; TRIMA ACCEL ENHANCED PLATELET, PLASMA, RBC SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT TRIMA ACCEL; TRIMA ACCEL ENHANCED PLATELET, PLASMA, RBC SET Back to Search Results
Catalog Number 80440
Device Problems Incorrect, Inadequate or Imprecise Result or Readings (1535); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Patient Involvement (2645)
Event Date 05/09/2019
Event Type  malfunction  
Manufacturer Narrative
Investigation: the device history records (dhr) were reviewed for this lot.There were noe vents noted in the dhr that would have contributed to the elevated wbc count experienced by the customer.The run data file (rdf) was analyzed for this event.A definitive root cause for the observed leukoreduction failure remains undetermined at this time.The analysis of the run data file did not find a conclusive cause for the higher-than-expected wbc content in the platelet product reported for this collection.No unusual process variable was identified and the signals in the run data file indicate that the trima accel system operated as intended.Based on the available information, it cannot be ruled out that the higher-than- expected wbc content in the platelet product could be donor-related.Investigation is in process.A follow-up report will be provided.
 
Event Description
The customer would like the run data file investigated to determine a possible cause for the elevated white blood cell (wbc) content in the platelet product.There was not a transfusion recipient or patient involved at the time of the residual white blood cell (rwbc) testing, therefore no patient information is reasonably known at the time of thee vent.Donor unit # : (b)(6).The platelet collection is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
This report is being filed to provide in root cause: a definitive root cause for the observed leukoreduction failure remainsundetermined at this time.The analysis of the run data file did not find a conclusive cause for thehigher-than-expected wbccontent in the platelet product reported for this collection.No unusual process variable wasidentified and the signals in the run data file indicate that the trima accel system operated asintended.Based on the available information, it cannot be ruled out that the higher-than-expected wbc content in the platelet product could be donor-related.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRIMA ACCEL
Type of Device
TRIMA ACCEL ENHANCED PLATELET, PLASMA, RBC SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
MDR Report Key8679595
MDR Text Key147860154
Report Number1722028-2019-00138
Device Sequence Number1
Product Code GKT
UDI-Device Identifier05020583804401
UDI-Public05020583804401
Combination Product (y/n)N
PMA/PMN Number
BK180231
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 06/07/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/01/2021
Device Catalogue Number80440
Device Lot Number1903181130
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Initial Date Manufacturer Received 05/16/2019
Initial Date FDA Received06/07/2019
Supplement Dates Manufacturer Received06/07/2019
Supplement Dates FDA Received06/14/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-